SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-16-582835
Filing Date
2016-05-09
Accepted
2016-05-09 08:15:32
Documents
2
Period of Report
2016-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d178557d8ka.htm 8-K/A 20040
2 EX-10.1 d178557dex101.htm EX-10.1 187402
  Complete submission text file 0001193125-16-582835.txt   208601
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 161629967
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences